Assignee
ESPERION THERAPEUTICS INC
US51 patents
Top patents by PatentIndex Score
US6506799B1Jan 14, 2003
Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
ESPERION THERAPEUTICS INC158 citations99
US6459003B1Oct 1, 2002
Ether compounds
ESPERION THERAPEUTICS INC80 citations99
US6410802B1Jun 25, 2002
Methods for synthesizing ether compounds and intermediates therefor
ESPERION THERAPEUTICS INC81 citations99
US6703422B2Mar 9, 2004
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC90 citations98
US6699910B2Mar 2, 2004
Ketone compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC77 citations98
US6673780B2Jan 6, 2004
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC88 citations98
US7335799B2Feb 26, 2008
Hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC49 citations97
US9006290B2Apr 14, 2015
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC17 citations96
US8623915B2Jan 7, 2014
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC20 citations96
US7838554B2Nov 23, 2010
Dihydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC21 citations96
US7812199B2Oct 12, 2010
Hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC24 citations96
US7576130B2Aug 18, 2009
Dihydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC30 citations96
US7405226B2Jul 29, 2008
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC38 citations96
US7335689B2Feb 26, 2008
Dihydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC27 citations96
US7192940B2Mar 20, 2007
Ether compounds
ESPERION THERAPEUTICS INC37 citations96
US7119221B2Oct 10, 2006
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC32 citations96
US6909014B2Jun 21, 2005
Intermediates for the synthesis of ether compounds
ESPERION THERAPEUTICS INC35 citations96
US6831105B2Dec 14, 2004
Compositions comprising ether compounds and pharmaceutical uses therefor
ESPERION THERAPEUTICS INC48 citations96
US6790953B2Sep 14, 2004
Ether compounds
ESPERION THERAPEUTICS INC52 citations96
US6680203B2Jan 20, 2004
Fourier transform mass spectrometry of complex biological samples
ESPERION THERAPEUTICS INC146 citations96
US6646170B2Nov 11, 2003
Intermediates for the synthesis of ether compounds
ESPERION THERAPEUTICS INC51 citations96
US6329341B1Dec 11, 2001
Method of treating septic shock
ESPERION THERAPEUTICS INC61 citations96
US9624152B2Apr 18, 2017
Hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC17 citations94
US9452964B2Sep 27, 2016
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC22 citations94
US6617134B1Sep 9, 2003
Dimer of molecular variant of apolipoprotein and processes for the production thereof
ESPERION THERAPEUTICS INC56 citations94
US6713507B2Mar 30, 2004
Ether compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC52 citations93
US6090921AJul 18, 2000
Process for purifying apolipoprotein a or apolipoprotein e
ESPERION THERAPEUTICS INC45 citations93
US7304093B2Dec 4, 2007
Ketone compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC34 citations92
US10118881B2Nov 6, 2018
Hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC14 citations90
US10047028B2Aug 14, 2018
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC12 citations90
US6953840B2Oct 11, 2005
Methods of using non-human animal Apolipoprotein A-I protein
ESPERION THERAPEUTICS INC21 citations90
US6559284B1May 6, 2003
Process for purifying a protein
ESPERION THERAPEUTICS INC30 citations90
US6506879B1Jan 14, 2003
Purified Apo A and Apo E compounds and methods for using them
ESPERION THERAPEUTICS INC23 citations90
US5990081ANov 23, 1999
Purified APO A and APO E compounds and methods for using them
ESPERION THERAPEUTICS INC35 citations90
US6423830B1Jul 23, 2002
Process for purifying apolipoprotein A or apolipoprotein E
ESPERION THERAPEUTICS INC39 citations89
US10941095B2Mar 9, 2021
Hydroxyl compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC3 citations82
US6974702B2Dec 13, 2005
Fourier transform mass spectrometry of complex biological samples
ESPERION THERAPEUTICS INC9 citations71
US11407705B2Aug 9, 2022
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC1 citations70
US11116739B2Sep 14, 2021
Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
ESPERION THERAPEUTICS INC2 citations66
US8975300B2Mar 10, 2015
Ketone compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC3 citations63
US7709515B2May 4, 2010
Compositions comprising ether compounds and pharmaceutical uses therefor
ESPERION THERAPEUTICS INC2 citations63
US12404227B2Sep 2, 2025
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US12398087B2Aug 26, 2025
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US11987548B2May 21, 2024
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US11926584B2Mar 12, 2024
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US11760714B2Sep 19, 2023
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US11613511B2Mar 28, 2023
Methods of making bempedoic acid and compositions of the same
ESPERION THERAPEUTICS INC0 citations60
US12344578B2Jul 1, 2025
Salt forms of bempedoic acid and methods for using the same
ESPERION THERAPEUTICS INC0 citations59
US11744816B2Sep 5, 2023
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
ESPERION THERAPEUTICS INC1 citations56
US10912751B2Feb 9, 2021
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
ESPERION THERAPEUTICS INC1 citations56
Showing the top 50 of 51 patents by PatentIndex Score.